1.0South Africa Gazettehttps://southafricagazette.comshadminhttps://southafricagazette.com/author/shadmin-s/bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test - South Africa Gazetterich600338<blockquote class="wp-embedded-content" data-secret="hzmBr2b1lY"><a href="https://southafricagazette.com/biolytical-laboratories-inc-receives-health-canada-authorization-for-its-insti-multiplex-hiv-1-2-syphilis-antibody-test/">bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://southafricagazette.com/biolytical-laboratories-inc-receives-health-canada-authorization-for-its-insti-multiplex-hiv-1-2-syphilis-antibody-test/embed/#?secret=hzmBr2b1lY" width="600" height="338" title="“bioLytical Laboratories Inc. Receives Health Canada Authorization for its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test” — South Africa Gazette" data-secret="hzmBr2b1lY" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
</script>
bioLytical Laboratories Inc. announced today that it has launched its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test for professional use in Canada INSTI® Multiplex HIV-1/2 Syphilis Antibody Test bioLytical has received Health Canada authorization to sell its INSTI® Multiplex HIV-1/2 Syphilis Antibody Test across Canada for professional use in point-of-care settings By providing results for two […]https://ci6.googleusercontent.com/proxy/UleuIrIbHfVHtLTxt8uiI7it5HuuR4zZj717DD5Ik0o_LKwzr_HTTzFd_DwxHYfBq4Wey3bTfbWqQ37KoMS4Ih91a82pJ80tSWMTGYo4_yhcw6w_emnH4W5hJE1ffLJ0QC6cEtLvxvlMcA1v7dWi2WklZSnfhbY3GzOc4tHIWes-a0X7uM8BysHP_s1t7w8sT_b9cpo=s0-d-e1-ft#https://ml.globenewswire.com/media/4adaf035-89ca-428d-a01d-9bf5c3f05e4b/medium/insti-multiplex-hiv-1-2-syphilis-antibody-test.png